Baxter International | BAX - 販売および管理費

株価
18.71
毎日の変更
0.57 3.14%
毎月
9.48%
毎年
-34.44%
Q2 予測
16.68




販売および管理費 変化する 日付
Abbott USD 3.27B 138M 2026-03
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Fresenius EUR 819M 143M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
ICU Medical USD 155.81M 3.04M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
J&J USD 6.03B 719M 2026-03
Laboratory Of America USD 538.6M 13.8M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Quest Diagnostics USD 504M 3M 2025-12
Smith & Nephew USD 1.42B 65M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12